2[2]Parkin DM, Ohshima H, Srivatanakul P, et al. Cholangiocarcinoma:Epidemiology, mechanisms of carcinogenesis and prevention, cancer Epidemiol [J]. Biomarkers Prev, 1993; 2(6)∶537
3[3]Yamauroto M, Takasaki K, Nakano M, et al. Minute nodular intrahepatic cholangiocarcinoma [J]. Cancer, 1998; 82(11)∶2145
4[4]Primary liver cancer group of Japan. Clinicopathologic features and result of surgical treatment [J]. Ann Surg, 1990; 211(3)∶277
5[5]Chen MF, Jan YY, Chen TC. Clinical studies of mucin-producing cholangiocellular carcinoma [J]. Ann Surg, 1998; 227(1)∶63
6[6]Sasaki A, Aramaki M, Kawano K, et al.Intrahepatic peripheral cholangiocarcinoma:mode of spread and choice of surgical treatment [J]. Br J Surg,1998; 85(9)∶1206
7[7]Nakajima T, Kondo Y, Miyazaki M, et al.A histopathological study of 102 cases of intrahepatic cholangiocarcinoma:histologic classification and modes of spread [J]. Hum Pathol, 1988; 19(10)∶1228
8[8]Chen MF, Jan YY, Wang CS, et al.A reappraisal of cholangiocarcinoma in patients with hepatolithiasis [J]. Cancer, 1993； 71(8)∶2461
9[9]Keiding S, Hansen SB, Hojgaard H, et al.Delection of cholangiocarcinoma in primary sclerosing cholangitis by position emission to mography [J]. Hepatology, 1998; 28(3)∶700
10[10]Nakeeb A, Lipsett PA, Lillemoe K, et al. Biliary carcinoembryonic antigen level are a marker for cholangiocarcinoma [J]. Am J Surg,1996; 171(3)∶147
